European Journal of Neurology 2025 Aug;32(8):e70328. doi: 10.1111/ene.70328. Stewart J Tepper, David W Dodick, Michel Lanteri-Minet , David Dolezil, Raquel Gil-Gouveia, Christian Lucas, Karolina Piasecka-Stryczynska, Gyöngyi Szabó, Daniel D Mikol, Mahan Chehrenama, Denise E Chou, Zilu Liu, Gabriel Paiva da Silva Lima Abstract Background: Erenumab-induced medication overuse headache (MOH) remission in participants with
